Harrow, Inc. Operating Expenses
Harrow, Inc. (HROW) reported Operating Expenses of $61.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Harrow, Inc. operating expenses for the quarter ending 2026-06-30 was $61.37M, a 69.99% increase year-over-year.
- Harrow, Inc. operating expenses for the quarter ending 2026-03-31 was $49.13M, a 12.83% increase year-over-year.
- Harrow, Inc. operating expenses for the quarter ending 2025-12-31 was $55.03M, a 38.28% increase year-over-year.
- Harrow, Inc. operating expenses for the quarter ending 2025-09-30 was $39.18M, a 9.08% increase year-over-year.
- Harrow, Inc. operating expenses for fiscal 2025 was $173.85M, a 22.82% increase from fiscal 2024.
- Harrow, Inc. operating expenses for fiscal 2024 was $141.55M, a 57.06% increase from fiscal 2023.
- Harrow, Inc. operating expenses for fiscal 2023 was $90.12M, a 47.03% increase from fiscal 2022.
- Harrow, Inc. operating expenses for fiscal 2022 was $61.29M, a 16.42% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $61.37M 10-Q · filed 2026-08-10 | $110.50M 10-Q · filed 2026-08-10 | $165.53M derived: sum of 3 quarters · filed 2026-08-10 | $204.71M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $49.13M 10-Q · filed 2026-05-11 | $104.16M derived: sum of 2 quarters · filed 2026-05-11 | $143.34M derived: sum of 3 quarters · filed 2026-05-11 | $179.44M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $55.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $94.21M derived: sum of 2 quarters · filed 2026-03-02 | $130.31M derived: sum of 3 quarters · filed 2026-08-10 | $173.85M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $39.18M 10-Q · filed 2025-11-10 | $75.28M derived: sum of 2 quarters · filed 2026-08-10 | $118.82M 10-Q · filed 2025-11-10 | $158.62M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $36.10M 10-Q · filed 2026-08-10 | $79.64M 10-Q · filed 2026-08-10 | $119.44M derived: sum of 3 quarters · filed 2026-08-10 | $155.36M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $43.54M 10-Q · filed 2026-05-11 | $83.34M derived: sum of 2 quarters · filed 2026-05-11 | $119.25M derived: sum of 3 quarters · filed 2026-05-11 | $154.12M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $39.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $75.72M derived: sum of 2 quarters · filed 2026-03-02 | $110.58M derived: sum of 3 quarters · filed 2026-03-02 | $141.55M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $35.92M 10-Q · filed 2025-11-10 | $70.79M derived: sum of 2 quarters · filed 2025-11-10 | $101.75M 10-Q · filed 2025-11-10 | $131.68M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $34.87M 10-Q · filed 2025-08-11 | $65.83M 10-Q · filed 2025-08-11 | $95.76M derived: sum of 3 quarters · filed 2026-03-02 | $118.21M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $30.96M 10-Q · filed 2025-05-08 | $60.89M derived: sum of 2 quarters · filed 2026-03-02 | $83.34M derived: sum of 3 quarters · filed 2026-03-02 | $104.46M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $52.38M derived: sum of 2 quarters · filed 2026-03-02 | $73.50M derived: sum of 3 quarters · filed 2026-03-02 | $90.12M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $22.45M 10-Q · filed 2024-11-14 | $43.57M derived: sum of 2 quarters · filed 2024-11-14 | $60.19M 10-Q · filed 2024-11-14 | $76.14M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $21.12M 10-Q · filed 2024-08-07 | $37.74M 10-Q · filed 2024-08-07 | $53.68M derived: sum of 3 quarters · filed 2024-08-07 | $69.88M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | $16.62M 10-Q · filed 2024-05-13 | $32.56M derived: sum of 2 quarters · filed 2024-05-13 | $48.76M derived: sum of 3 quarters · filed 2024-05-13 | $63.86M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $15.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $32.14M derived: sum of 2 quarters · filed 2024-03-19 | $47.24M derived: sum of 3 quarters · filed 2024-03-19 | $61.29M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $16.20M 10-Q · filed 2023-11-13 | $31.30M derived: sum of 2 quarters · filed 2023-11-13 | $45.35M 10-Q · filed 2023-11-13 | $62.21M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $15.10M 10-Q · filed 2023-08-09 | $29.16M 10-Q · filed 2023-08-09 | $46.02M derived: sum of 3 quarters · filed 2023-08-09 | $63.50M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $14.06M 10-Q · filed 2023-05-11 | $30.92M derived: sum of 2 quarters · filed 2023-05-11 | $48.40M derived: sum of 3 quarters · filed 2023-05-11 | $57.95M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $16.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $34.34M derived: sum of 2 quarters · filed 2023-03-23 | $43.89M derived: sum of 3 quarters · filed 2023-03-23 | $52.65M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $17.48M 10-Q · filed 2022-11-14 | $27.03M derived: sum of 2 quarters · filed 2022-11-14 | $35.78M 10-Q · filed 2022-11-14 | $43.82M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $9.55M 10-Q · filed 2022-08-09 | $18.30M 10-Q · filed 2022-08-09 | $26.34M derived: sum of 3 quarters · filed 2022-08-09 | $35.44M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $8.76M 10-Q · filed 2022-05-05 | $16.79M derived: sum of 2 quarters · filed 2022-05-05 | $25.89M derived: sum of 3 quarters · filed 2022-05-05 | $33.96M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $17.14M derived: sum of 2 quarters · filed 2022-03-10 | $25.20M derived: sum of 3 quarters · filed 2022-03-10 | $34.02M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $9.11M 10-Q · filed 2021-11-09 | $17.17M derived: sum of 2 quarters · filed 2021-11-09 | $25.99M 10-Q · filed 2021-11-09 | $34.10M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $8.07M 10-Q · filed 2021-08-10 | $16.89M 10-Q · filed 2021-08-10 | $25.00M derived: sum of 3 quarters · filed 2021-08-10 | $38.09M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | $8.82M 10-Q · filed 2021-05-11 | $16.93M derived: sum of 2 quarters · filed 2021-05-11 | $30.02M derived: sum of 3 quarters · filed 2021-05-11 | $39.08M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $21.20M derived: sum of 2 quarters · filed 2021-03-08 | $30.26M derived: sum of 3 quarters · filed 2021-03-08 | $39.21M 10-K · filed 2021-03-08 | $39.22M 10-K · filed 2020-03-13 |
| 2019-09-30 | $13.09M 10-Q · filed 2020-11-09 | $22.15M derived: sum of 2 quarters · filed 2020-11-09 | $31.10M 10-Q · filed 2020-11-09 | $40.54M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $9.06M 10-Q · filed 2020-08-10 | $18.01M 10-Q · filed 2020-08-10 | $27.45M derived: sum of 3 quarters · filed 2020-08-10 | $34.65M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $8.95M 10-Q · filed 2020-05-11 | $18.39M derived: sum of 2 quarters · filed 2020-05-11 | $25.59M derived: sum of 3 quarters · filed 2020-05-11 | $32.44M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $16.64M derived: sum of 2 quarters · filed 2020-03-13 | $23.49M derived: sum of 3 quarters · filed 2020-03-13 | $30.07M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $7.20M 10-Q · filed 2019-11-13 | $14.05M derived: sum of 2 quarters · filed 2019-11-13 | $20.62M 10-Q · filed 2019-11-13 | $26.65M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | $6.85M 10-Q · filed 2019-08-14 | $13.43M 10-Q · filed 2019-08-14 | $19.46M derived: sum of 3 quarters · filed 2019-08-14 | $25.30M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $6.58M 10-Q · filed 2019-05-09 | $12.61M derived: sum of 2 quarters · filed 2019-05-09 | $18.45M derived: sum of 3 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $11.88M derived: sum of 2 quarters · filed 2019-03-12 | $25.43M 10-K · filed 2019-03-12 | ||
| 2017-09-30 | $5.84M 10-Q · filed 2018-11-13 | $19.40M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |